ghk-cu injections Dosage and Protocol: A Medical Provider's Guide to the 30-Day Cycle GHK-Cu Peptide Therapy: The Definitive
Description
The objective response rate in the study was 83.3% and median overall survival was 35.7 months
These molecules can hurt nerve cells and lead to nerve problems
Click here for the new paper in Peptides and here for the paper in Metabolism
We had discussed it a few visits prior
Whats one thing you wish more people understood about this work
